Nathaniel Barnes, MD

Disclosure information not submitted.

Presentation(s):

• Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment | Sponsored by: Urovant Pharma

  Sunday, April 30, 2023
  12:00 PM – 1:00 PM CST